Genistein has indicated upregulation of cyclin D1 and CDK4 expression, thereby promoting the proliferation and viability of ovarian cancer OVCAR‐5 cells (Wang et al. 2021). The gene discussed is CDK4; the disease is ovarian carcinoma.